Long-term prophylaxis in hereditary angioedema: Real-world treatment patterns and healthcare resource utilization
{{output}}
Background: Multiple non-androgen long-term prophylaxis (LTP) therapies have been approved in the United States to prevent hereditary angioedema (HAE) attacks. Real-world data on treatment compliance, healthcare resource utilizat... ...
